webinar register page

Webinar banner
ICRF Presents Brilliant Minds Webinar Series: Living with Lung Cancer - A Look at Promising Cancer Therapies


Jun 25, 2020 11:24 AM

* Required information


Linnea Olson
Linnea Olson has been living with non-small cell lung cancer for more than fifteen years. During that time she has enrolled in three phase I clinical trials. Acutely aware that experimental therapeutics have extended her life far beyond what was once thought possible, Linnea is a vocal advocate for medical research. In addition to her blog (outlivinglungcancer.com), Linnea has worked as a peer reviewer for the Congressionally Directed Medical Research Program, served on the Mass General Cancer Center's Patient and Family Advisory Council, and is a member of the International Lung Cancer Survivorship Council planning committee for LUNGevity. Linnea places a strong emphasis on activism versus advocacy and believes that complacency equals complicity. Clinical trials are vitally important but also could be made more user friendly, and Linnea is adamant that in order to do so, it is important to listen to the patient voice.
Ravid Straussman
Ravid Straussman, MD, PhD, completed a BS summa cum laude at the Hebrew University Hadassah Medical School. He earned his MSc in medical biochemistry and then graduated the MD/PhD program of Hadassah Medical School. In 2013, after completing his MD internship and two postdoctoral training periods at the Hebrew University, as well as at the Broad Institute of Harvard and MIT, he joined the Weizmann Institute as a principal investigator. The Straussman lab studies mechanisms of resistance to anti-cancer therapies. Specifically, the laboratory focuses on understanding the roles of the tumor microenvironment and the tumor microbiome on resistance to cytotoxic, targeted and immune mediated anti-cancer therapies.